| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $40.04 | $4,644.64 | -3.2% | |
| May 19, 2025 | PRPO Precipio, Inc. | Sandberg Richard A | Director | Buy | 714 | $8.21 | $5,861.94 | +2.8% | |
| May 19, 2025 | BDSX Biodesix Inc | Schuler Jack W | - | Buy | 4,723,239 | $0.28 | $1,316,624.50 | +13.0% | |
| May 16, 2025 | PSNL Personalis, Inc. | Tachibana Aaron | CFO And COO | Sell | 1,291 | $4.95 | $6,390.45 | -0.8% | |
| May 16, 2025 | PSNL Personalis, Inc. | Moore Stephen Michael | SVP And Chief Legal Officer | Sell | 1,675 | $4.95 | $8,291.25 | -2.5% | |
| May 16, 2025 | PSNL Personalis, Inc. | Chen Richard | Chief Medical Officer And EVP | Sell | 910 | $4.95 | $4,504.50 | -0.7% | |
| May 16, 2025 | RDNT Radnet, Inc. | Levitt Lawrence L | Director | Sell | 5,000 | $61.09 | $305,450.00 | -2.9% | |
| May 16, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 29,000 | $151.93 | $4,405,900.00 | -13.1% | |
| May 16, 2025 | RDNT Radnet, Inc. | Forthuber Stephen M | Pres &Coo-eastern Operations | Sell | 18,820 | $60.34 | $1,135,598.80 | -3.4% | |
| May 15, 2025 | CRL Charles River Laboratories International, Inc. | Massaro George | Director | Sell | 140 | $137.57 | $19,260.48 | -0.8% | |
| May 15, 2025 | RDNT Radnet, Inc. | Hames Norman R | Pres And Coo-west Operations | Sell | 8,447 | $60.00 | $506,820.00 | -3.0% | |
| May 14, 2025 | CRL Charles River Laboratories International, Inc. | Massaro George | Director | Sell | 140 | $140.73 | $19,702.90 | -0.5% | |
| May 14, 2025 | WGS Genedx Holdings Corp. | Meister Keith A. | Director, 10% Owner | Buy | 50,000 | $60.16 | $3,007,997.24 | +0.8% | |
| May 13, 2025 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W | EVP, Corp Strategy &Develop | Sell | 500 | $145.41 | $72,705.00 | -2.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.